Correlation Between Enlivex Therapeutics and Zenas BioPharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Zenas BioPharma, Common, you can compare the effects of market volatilities on Enlivex Therapeutics and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Zenas BioPharma,.

Diversification Opportunities for Enlivex Therapeutics and Zenas BioPharma,

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Enlivex and Zenas is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Zenas BioPharma, go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Zenas BioPharma,

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Zenas BioPharma,. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 2.89 times less risky than Zenas BioPharma,. The stock trades about -0.27 of its potential returns per unit of risk. The Zenas BioPharma, Common is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  643.00  in Zenas BioPharma, Common on November 29, 2024 and sell it today you would earn a total of  32.00  from holding Zenas BioPharma, Common or generate 4.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Enlivex Therapeutics  vs.  Zenas BioPharma, Common

 Performance 
       Timeline  
Enlivex Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Zenas BioPharma, Common 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.

Enlivex Therapeutics and Zenas BioPharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enlivex Therapeutics and Zenas BioPharma,

The main advantage of trading using opposite Enlivex Therapeutics and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.
The idea behind Enlivex Therapeutics and Zenas BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities